The small biotech plans to go head-to-head with Shingrix with an assist from some former GSK execs, one being Operation Warp Speed’s chief scientific advisor Moncef Slaoui, Ph.D. Before advising ...

A small company developing a new shingles vaccine announced Monday that the venture capitalist Moncef Slaoui, who previously ran the U.S. government’s Operation Warp Speed Covid vaccine effort ...

Operation Warp Speed's former science chief Moncef Slaoui is to lead research at a new mega-biotech called Centessa, formed by the merger of 10 privately-held life science startups. President Joe ...

Slaoui is noted for his work with Operation Warp Speed, the COVID-19 vaccine project launched by the Trump administration, where he was scientific head until he stepped down in January.

There have been several high-profile deals between big pharma companies and ADC specialists in recent years. Image credit: Shutterstock/ afry_harvy. Taiho Pharmaceutical has agreed to acquire ...

A Seat­tle biotech try­ing to take on one of the world’s biggest vac­cines has nabbed a megaround. It al­so named for­mer Op­er­a­tion Warp Speed chief … ...